PerSimiO

Predicting Fracture Risk for Patients with Cancer and Osteoporosis

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in January 2015 by Prof. Zohar Yosibash, Dr. Nir Trabelsi, and Prof. MD Charles Milgrom, PerSimiO operates with 1–10 employees. The company has raised $955K across two funding rounds and holds a patent for its technology. In August 2017, PerSimiO secured a grant from the Israel Innovation Authority.

Business overview

PerSimiO is a Health Tech & Life Sciences company specializing in digital healthcare and medical decision support. The company develops proprietary simulation technology to predict fracture risk for patients with cancer and osteoporosis, validated through ex-vivo experiments. Its patented technology, offered as a fully automated web-service, integrates with hospital PACS or can be accessed via a web-browser as a locally hosted application. PerSimiO's products, including Simfini-TUMOR, Simfini-IMPLANT, Simfini-OSTEO, Simfini-DIABETES, and Simfini-SENIOR, target the diagnosis and treatment of conditions that weaken bones, aiming to optimize treatment and improve outcomes at reduced costs. The company's core technologies include platforms, software, artificial intelligence, and machine learning, serving healthcare providers globally.

Company Intelligence Q&A

What is PerSimiO's core technology?
PerSimiO offers a superior prediction technology based on proprietary simulation of the response of human bones to load. This technology has been validated by ex-vivo experiments on a large cohort of human femurs, using routine CT scans.
When was PerSimiO founded and by whom?
PerSimiO was founded in January 2015 by Prof. Zohar Yosibash, Dr. Nir Trabelsi, and Prof. MD Charles Milgrom.
What types of products does PerSimiO offer?
PerSimiO offers products such as Simfini-TUMOR, Simfini-IMPLANT, Simfini-OSTEO, Simfini-DIABETES, and Simfini-SENIOR, designed for the diagnosis and treatment of diseases including osteoporosis, metastatic tumors, and bone-weakening injuries.
How does PerSimiO's technology integrate into healthcare systems?
PerSimiO's patented technology is a fully automated web-service that can be integrated within a hospital PACS or accessed from a web-browser as a locally hosted web-application.